Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe two screenshots show minor visual and layout updates to the page header, navigation, and footer, with no changes to the record history content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference11%

- Check45 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content now reflects the newer release identifier; other substantive content remains unchanged.SummaryDifference0.3%

- Check60 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; Back to Top element removed (minor UI change).SummaryDifference0.6%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.6%

- Check74 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference30%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.